From our data, it could be speculated that H. pylori does not have the ability to activate the NKG2D–NKG2DL system, and this might eventually favour stomach cancer development as a long‐term sequel of H. pylori infection, because of impaired innate antitumour immunity. The gene discussed is KLRK1; the disease is gastric cancer.